Author:
Zhang Lu,Lai Fangfang,Chen Xiaoguang,Xiao Zhiyan
Funder
CAMS Innovation Fund for Medical Sciences (CIFMS
Chinese Academy of Medical Sciences
Ministry of Science and Technology, China
Subject
Materials Chemistry,Computer Graphics and Computer-Aided Design,Physical and Theoretical Chemistry,Spectroscopy
Reference29 articles.
1. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion;Platten;Canc. Res.,2012
2. Indoleamine 2, 3 dioxygenase and metabolic control of immune responses;Munn;Trends Immunol.,2013
3. New 4-amino-1, 2, 3-triazole inhibitors of indoleamine 2, 3-dioxygenase form a long-lived complex with the enzyme and display exquisite cellular potency;Alexandre;ChemBioChem,2018
4. BMS-986205, an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic (PD) activity, alone and in combination with nivolumab (nivo) in advanced cancers in a phase 1/2a trial;Siu;Canc. Res.,2017
5. INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for immuno-oncology;Yue;ACS Med. Chem. Lett.,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献